Bioactivty and controlled release studies of ranibizumab from polymeric carriers
Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in developed societies. Ranibizumab is an anti-angiogenic agent commonly prescribed to treat AMD. However several issues associated with its frequent intravitreal injections have intensified the need for a sustaine...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
2018
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10356/73341 |